ISIS Pharmaceuticals (Nasdaq: ISIS) is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
Recent Mentions on Fool.com
- 3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett
- Why Isis Pharmaceuticals Continues to Impress
- Why Zynga Inc., Isis Pharmaceuticals, and Vipshop Holdings Ltd. Are Today's 3 Best Stocks
- Isis Pharmaceuticals Q4 Revenue More Than Doubles; Loss Widens Anyway
- 3 Things to Watch When Isis Pharmaceuticals Reports 2013 Earnings